ArticleScientific reports2026
Structurally diverse secondary metabolites from the dung-inhabiting fungus Botryotrichum murorum.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
A combination of confidence-aware MS/MS-based metabolomics and conventional chemical screening approaches was employed to investigate the metabolome of Botryotrichum murorum DSM 113281, isolated from tortoise dung. The metabolomic survey revealed a high degree of chemical diversity; however, low production rates necessitated large-scale solid-state cultivation to purify the major constituents. This approach led to the discovery of tortoisellide A (1), which features a rare polyketide γ-lactol scaffold, an unprecedented thio-substituted analogue 2 of the 14-membered bis-macrolactone antibiotic grahamimycin A, alongside the known sesquiterpenoid eremophilane cryptosphaerolide (3) and isocochliodinol (4). All planar structures were elucidated by HR-MS and NMR analysis. Tortoisellide A (1) displayed pronounced tautomerism at its hemiacetal carbon C-23, manifesting in the duplication of most NMR signals. Mosher ester analysis supported the assignment of the 2'S configuration of compound 2, while the configurations at C-2 and C-8 were tentatively assigned by analogy to the natural (-)-grahamimycin A1. The previously unassigned side-chain configuration of 3 was determined as 17S, 19S, 21S by NMR chemical shift and J-based configurational analyses (Murata's method) supported by computational modeling. Compounds showed varying degrees of cytotoxicity against mammalian cell lines, with isocochliodinol being most active displaying potency in the nanomolar range. The metabolite diversity of B. murorum broadens the chemical repertoire of coprophilous fungi and knowledge on the diversification of secondary metabolism in the Sordariales.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.